LB Pharmaceuticals Inc Common Stock
General ticker "LBRX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $56.0M (TTM average)
LB Pharmaceuticals Inc Common Stock follows the US Stock Market performance with the rate: 26.3%.
Estimated limits based on current volatility of 5.6%: low 20.14$, high 22.55$
Short-term LBRX quotes
Long-term LBRX plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $2.81MM | $11.38MM | $64.83MM |
| Operating Income | $-2.81MM | $-11.38MM | $-64.83MM |
| Non-Operating Income | $-11.54MM | $5.10MM | $1.73MM |
| Interest Expense | $2.15MM | $4.83MM | $0.00MM |
| R&D Expense | $1.35MM | $7.84MM | $51.17MM |
| Income(Loss) | $-14.35MM | $-6.27MM | $-63.10MM |
| Taxes | $0.00MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $-14.35MM | $-6.28MM | $-63.10MM |
| Stockholders Equity | $-28.81MM | $-34.47MM | $-94.55MM |
| Assets | $21.49MM | $45.66MM | $33.53MM |
| Operating Cash Flow | $-2.73MM | $-12.09MM | $-53.05MM |
| Capital expenditure | $0.00MM | $0.03MM | $0.77MM |
| Investing Cash Flow | $0.12MM | $-28.01MM | $23.23MM |
| Financing Cash Flow | $22.96MM | $33.68MM | $38.31MM |
| Earnings Per Share** | $-4.05 | $-1.77 | $-17.83 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.